AM
CVS icon

Atwater Malick’s CVS Health CVS Stock Holding History

Atwater Malick’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-81,303
Closed -$6.48M – 78
2024
Q1 		$6.48M Sell
81,303
-1,882
-2% -$144K 2.29% 20
2023
Q4 		$6.57M Buy
83,185
+1,678
+2% +$119K 2.57% 17
2023
Q3 		$5.69M Buy
81,507
+1,065
+1% +$75.5K 2.5% 18
2023
Q2 		$5.56M Buy
80,442
+4,423
+6% +$315K 2.38% 20
2023
Q1 		$5.65M Buy
76,019
+3,500
+5% +$293K 2.65% 20
2022
Q4 		$6.76M Buy
72,519
+1,603
+2% +$155K 3.33% 18
2022
Q3 		$6.76M Buy
70,916
+1,153
+2% +$114K 3.78% 11
2022
Q2 		$6.46M Buy
69,763
+1,732
+3% +$169K 3.4% 15
2022
Q1 		$6.88M Buy
68,031
+1,758
+3% +$185K 3.32% 15
2021
Q4 		$6.84M Buy
66,273
+1,194
+2% +$110K 3.17% 17
2021
Q3 		$5.52M Buy
65,079
+2,205
+4% +$185K 2.92% 20
2021
Q2 		$5.25M Buy
62,874
+3,121
+5% +$256K 2.9% 20
2021
Q1 		$4.5M Sell
59,753
-2,757
-4% -$201K 2.76% 20
2020
Q4 		$4.27M Buy
62,510
+1,434
+2% +$93.3K 2.68% 22
2020
Q3 		$3.57M Buy
61,076
+1,917
+3% +$119K 2.5% 22
2020
Q2 		$3.84M Buy
59,159
+1,936
+3% +$122K 3.03% 20
2020
Q1 		$3.4M Buy
57,223
+4,298
+8% +$287K 3.26% 19
2019
Q4 		$3.93M Buy
52,925
+1,259
+2% +$88.4K 3.13% 21
2019
Q3 		$3.26M Buy
51,666
+4,415
+9% +$262K 2.74% 23
2019
Q2 		$2.58M Buy
47,251
+3,668
+8% +$198K 2.36% 24
2019
Q1 		$2.35M Buy
43,583
+4,943
+13% +$305K 2.3% 24
2018
Q4 		$2.53M Buy
+38,640
New +$2.88M 2.83% 22

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Atwater Malick's CVS Position: Q2 2024 in Review

Atwater Malick sold out of CVS Health (CVS) in Q2 2024, closing a stake of 81,303 shares — an estimated $6.48M sold.

Atwater Malick first reported a position in CVS in Q4 2018 and held it in 22 quarters. The position peaked at $6.88M in Q1 2022. 1,911 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • Atwater Malick reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • Atwater Malick sold 81,303 CVS Health shares in Q2 2024, an estimated $6.48M.
  • Atwater Malick first reported a position in CVS Health in Q4 2018 and held it in 22 quarters.
  • Atwater Malick's CVS Health position peaked at $6.88M in Q1 2022.
  • 1,911 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Atwater Malick's 13F filing for Q2 2024, filed 17 Jul 2024.